NCT00977301View on ClinicalTrials.gov

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
HIV Infections
Interventions
DRUG

fosamprenavir/ritonavir

16 days 700mg/100mg RTV BID

DRUG

olanzapine

15 mg olanzapine single dose

DRUG

olanzapine

10 mg olanzapine single dose

Trial Locations (1)

Unknown

CRCN, Radboud Universtity Nijmegen Medical Centre, Nijmegen

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT00977301 - Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA) | Biotech Hunter | Biotech Hunter